Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice

Reproductive Toxicology

Volumn 12, Issue 4, 1998, Pages 457-463

  Lankas, George R ^a   Wise, L David ^a   Cartwright, Mark E ^a   Pippert, Todd ^a   Umbenhauer, Diane R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVERMECTIN; AVERMECTIN B1 A; CHEMICAL TERATOGEN; DRUG DERIVATIVE; GLYCOPROTEIN P; IVERMECTIN; PLACENTA PROTEIN;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH DEFECT; CHEMICAL TERATOGENESIS; CLEFT PALATE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FETUS; GENETICS; GENOTYPE; HETEROZYGOTE; IATROGENIC DISEASE; MALE; METABOLISM; MOUSE; NONHUMAN; NUTRITIONAL DEFICIENCY; PHYSIOLOGY; PLACENTA; PREGNANCY; PRENATAL EXPOSURE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPONTANEOUS MUTATION;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CLEFT PALATE; FEMALE; GENOTYPE; IVERMECTIN; MALE; MICE; P-GLYCOPROTEIN; PLACENTA; PREGNANCY;

EID: 0032129118     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(98)00027-6     Document Type: Article

References (27)

1. Goldstein L.J., Galski H., Fojo A., Willingham M., Lai S.L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G., Lieber M., Cossman J., Gottesman M., Pastan I. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 8:1989;116-124.
2. Gottesman M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem. 62:1993;385-427.
3. Chin J.E., Soffir R., Noonan K., Choi K., Roninson I. Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol. 9:1989;3808-3820.
4. Croop J.M., Raymond M., Haber D., Devault A., Arceci R.J., Gros P., Housman D.E. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol. 9:1989;1346-1350.
5. Hsu S.I., Lothstein L., Horwitz S.B. Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. J Biol Chem. 264:1989;12053-12062.
6. Borst P., Schinkel A.H. What have we learnt thus far from mice with disrupted P-glycoprotein genes? Eur J Cancer. 32A:1996;985-990.
7. Beck W.T. Biochemical analysis of multidrug resistance Drug accumulation and binding in P-glycoprotein-associated multidrug resistance . Roninson I.B. Molecular and cellular biology of multidrug resistance in tumor cells. 1991;215-227 Plenum Publishing Corp, New York.
8. Cordon-Cardo C., O'Brien J., Casals D., Rittman-Grauer L., Biedler J., Melamed M., Bertino J. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA. 86:1989;695-698.
9. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
10. Sparreboom A., van Asperen J., Mayer U., Schinkel A.H., Smit J.W., Meijer D.K.F., Borst P., Nooijen W.J., Beijnen J.H., van Tellingen O. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA. 94:1997;2031-2035.
11. Schinkel A.H., Wagenaar E., Mol C.A.A.M., van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 97:1996;2517-2524.
12. MacFarland A., Abramovich D.R., Ewen S.W., Pearson C.K. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem J. 26:1994;417-423.
13. Nakamura Y., Ikeda S., Furukawa T., Sumizawa T., Tani A., Akiyama S., Nagata Y. Function of P-glycoprotein expressed in placenta and mole. Biochem and Biophys Res Commun. 235:1997;849-853.
14. Lankas G.R., Cartwright M.E., Umbenhauer D. P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol Appl Pharmacol. 143:1997;357-365.
15. Umbenhauer D.R., Lankas G.R., Pippert T.R., Wise L.D., Cartwright M.A., Hall S.J., Beare C.M. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol Appl Pharmacol. 146:1997;88-94.
16. Lankas G.R., Gordon L.R. Toxicology. Campbell W.C. Ivermectin and abamectin. 1989;89-112 Springer-Verlag, Berlin/Heidelberg.
17. Pesticide Residues in Food Toxicology Evaluations (World Health Organization Joint Meeting on Pesticide Residues [JMPR]) Monograph on Abamectin 3, 1994.
18. Kartner N., Evernden-Porelle D., Bradley G., Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (London). 316:1985;820-823.
19. Kaufman M.H. Atlas of mouse development. 1992;428-429 Academic Press, San Diego.
20. Greenberger L.M., Croop J.M., Horwitz S.B., Arceci R.J. P-glycoproteins encoded by mdr1b in murine gravid uterus and multidrug resistant tumor lines are differentially glycosylated. FEBS Lett. 257:1989;419-421.
21. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A.A.M., van Deemter L., Smit J., van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M.J.M., Fibbe W.E., Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA. 94:1997;4028-4033.
22. Halley B.A., Nrarsimhan N.I., Venkataraman K., Taub R., Green-Erwin M.L., Andrew N.W., Wislocki P.G. Ivermectin and abamectin metabolism differences and similarities . Hutson D.H., Hawkins D.R., Paulson F.D., Struble C.B. Xenobiotics and food-producing animals: Metabolism and residues, ACS Symposium Series 503. 1992;203-216 American Chemical Society, Washington, DC.
23. Maynard M.S., Gruber V.F., Feely W.F., Alvaro R., Wislocki P.G. The fate of the 8,9-Z isomer of avermectin B1a in rats. J Agric Food Chem. 37:1989;1487-1491.
24. Zeng Z., Andrew N.W., Woda J.M., Halley B.A., Crouch L.S., Wang R.W. Role of Cytochrome P450 isoforms in the metabolism of abamectin and ivermectin in rats. J Agric Food Chem. 44:1996;3374-3378.
25. Qin Y., Sato T.S. Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development. Dev Dynam. 202:1995;172-180.
26. Didier A., Loor F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anti-Cancer Drugs. 7:1996;745-751.
27. Scala S., Akhmed N., Rao U.S., Paull K., Lan L.B., Dickstein B., Lee J.S., Elgemeie G.H., Stein W.D., Bates S.E. P-glycoprotein substrates and antagonists cluster into two distinct groups. Mol Pharmacol. 51:1997;1024-1033.